<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">Hydroxychloroquine was developed as an antimalarial drug and has been used for the treatment of rheumatoid arthritis and lupus erythematosus [
 <xref ref-type="bibr" rid="CR89">89</xref>–
 <xref ref-type="bibr" rid="CR91">91</xref>]. Due to its antiviral activity, hydroxychloroquine has also been used as an adjuvant therapy for AIDS [
 <xref ref-type="bibr" rid="CR92">92</xref>–
 <xref ref-type="bibr" rid="CR94">94</xref>]. It has been confirmed that hydroxychloroquine also has therapeutic effect against Ebola virus and dengue virus in in vitro studies [
 <xref ref-type="bibr" rid="CR95">95</xref>]. Recently, it has been reported that some COVID-19 patients benefited from the treatment with hydroxychloroquine [
 <xref ref-type="bibr" rid="CR96">96</xref>–
 <xref ref-type="bibr" rid="CR99">99</xref>]. Moreover, its effect for virus elimination could be reinforced by azithromycin [
 <xref ref-type="bibr" rid="CR97">97</xref>].
</p>
